Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy? [electronic resource]
Producer: 19940412Description: 149-59 p. digitalISSN:- 0340-7004
- Adult
- Aged
- Antibodies, Anti-Idiotypic -- immunology
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Neoplasm -- therapeutic use
- Antigens, Neoplasm -- immunology
- Antigens, Tumor-Associated, Carbohydrate -- therapeutic use
- Colorectal Neoplasms -- immunology
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Hypersensitivity, Delayed -- immunology
- Immunity, Cellular
- Immunoglobulin Idiotypes -- immunology
- Lymphocyte Activation
- Male
- Middle Aged
- Recombinant Fusion Proteins
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.